Govt studying options as Novartis-Cipla patent dispute moves to court – Hindu Business Line
0
The Government is examining if it can move on Indian drug-maker Cipla’s demand for revocation of Swiss company Novartis’ patents on respiratory drug Onbrez.
Both the companies are now fighting a case over the drug in court.
“We are keenly watching the case launched by Novartis this week against Cipla for copying its patented medicine. It will give us leads on how to deal with Cipla’s demand that Novartis’ patent be revoked.
“But more importantly, our team is working on whether we could indeed move on revocation, with the case going on in court,” a Department of Industrial Policy and Promotion (DIPP) official told Business Line.
Read more – Hindu Business Line